74. Sano Genetics

Founder: Dr Patrick Short, Charlotte Guzzo, William Jones
Founded: 2017
Website: sanogenetics.com

What if you could get personalised information – plus chances to contribute to the latest clinical research and trials – all based on your health and DNA?

It was this question – and the exciting opportunities it presents – that first captivated Dr Patrick Short, Charlotte Guzzo, and William Jones. Pretty soon, it led to the trio founding Sano Genetics in 2017, and the rest – as they say – is history.

Sano ‘matchmakes’ people living with rare and chronic diseases with research in personalised medicine, via an innovative online engagement platform.

Though broadly, it’s genetic history that Sano is more concerned with. Sano ‘matchmakes’ people living with rare and chronic diseases with research in personalised medicine, via an innovative online engagement platform. Utilising at-home testing kits, participants can take part at no cost to them, and also benefit from free genome sequencing and analysis. Users of Sano’s platform also get full transparency around how their data is used, and can easily provide feedback.

As Sano itself puts it, “we are enabling people to engage with the whole process, and help them to see and understand what sharing their DNA is doing for the many thousands of other people living with the very same conditions.”

With partners such as data management company Zetta Genomics, and biotech and pharma companies as clients, Sano Genetics is already making a name for itself at the nucleus of the industry.

Sano’s mission is twofold: improving the experience for those taking part in groundbreaking research, while simultaneously speeding up the development of new medicines.

With partners such as data management company Zetta Genomics, and biotech and pharma companies as clients, Sano Genetics is already making a name for itself at the nucleus of the industry. And, considering the conditions it’s helping to conduct research into – such as multiple sclerosis, Parkinson’s disease, and long COVID – it’s safe to say that Sano Genetics’ work is more timely and pressing than ever.